Evidence map›Paper›PMID 35460444›Full record

ReviewPlanta2022

Recent advancements in CRISPR/Cas technology for accelerated crop improvement.

Debajit Das, Dhanawantari L Singha, Ricky Raj Paswan, Naimisha Chowdhury, Monica Sharma, Palakolanu Sudhakar Reddy, Channakeshavaiah Chikkaputtaiah

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Planta, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Advances in Genome Editing Through Haploid Induction Systems.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Plants' Response to Abiotic Stress: Mechanisms and Strategies.International journal of molecular sciences · 2023
    Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Debajit DasBiological Sciences and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, Assam, 785006, India.ORCID http://orcid.org/0000-0001-7793-861X
Dhanawantari L SinghaBiological Sciences and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, Assam, 785006, India.ORCID http://orcid.org/0000-0001-5981-2933
Ricky Raj PaswanDepartment of Agricultural Biotechnology, Assam Agricultural University, Jorhat, Assam, 785013, India.ORCID http://orcid.org/0000-0001-9881-0455
Naimisha ChowdhuryBiological Sciences and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, Assam, 785006, India.ORCID http://orcid.org/0000-0002-5043-0776
Monica SharmaBiological Sciences and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, Assam, 785006, India.ORCID http://orcid.org/0000-0001-6204-3733
Palakolanu Sudhakar ReddyInternational Crop Research Institute for the Semi Arid Tropics (ICRISAT), Patancheru, Hyderabad, 502 324, India.ORCID http://orcid.org/0000-0002-5341-187X
Channakeshavaiah ChikkaputtaiahBiological Sciences and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, Assam, 785006, India. channakeshav@neist.res.in.ORCID http://orcid.org/0000-0001-7329-8643
North East Institute of Science and Technology · INAssam Agricultural University · INInternational Crops Research Institute for the Semi-Arid Tropics · IN

Funding

Council of Scientific and Industrial Research, India MLP-0007
6 · The paper itself

Abstract

MAIN

conclusionPrecise genome engineering approaches could be perceived as a second paradigm for targeted trait improvement in crop plants, with the potential to overcome the constraints imposed by conventional CRISPR/Cas technology. The likelihood of reduced agricultural production due to highly turbulent climatic conditions increases as the global population expands. The second paradigm of stress-resilient crops with enhanced tolerance and increased productivity against various stresses is paramount to support global production and consumption equilibrium. Although traditional breeding approaches have substantially increased crop production and yield, effective strategies are anticipated to restore crop productivity even further in meeting the world's increasing food demands. CRISPR/Cas, which originated in prokaryotes, has surfaced as a coveted genome editing tool in recent decades, reshaping plant molecular biology in unprecedented ways and paving the way for engineering stress-tolerant crops. CRISPR/Cas is distinguished by its efficiency, high target specificity, and modularity, enables precise genetic modification of crop plants, allowing for the creation of allelic variations in the germplasm and the development of novel and more productive agricultural practices. Additionally, a slew of advanced biotechnologies premised on the CRISPR/Cas methodologies have augmented fundamental research and plant synthetic biology toolkits. Here, we describe gene editing tools, including CRISPR/Cas and its imitative tools, such as base and prime editing, multiplex genome editing, chromosome engineering followed by their implications in crop genetic improvement. Further, we comprehensively discuss the latest developments of CRISPR/Cas technology including CRISPR-mediated gene drive, tissue-specific genome editing, dCas9 mediated epigenetic modification and programmed self-elimination of transgenes in plants. Finally, we highlight the applicability and scope of advanced CRISPR-based techniques in crop genetic improvement.

Indexed as

CRISPR-Cas SystemsPlant BreedingCrops, AgriculturalGenome, PlantPlants, Genetically ModifiedTechnologyBase editingCRISPR/CasCRISPR-TSKOCrop improvementGene drivePrime editingTransgene free

Identifiers

PMID35460444
OpenAlexW4224318571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.